BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Phenomenex, Inc. Release: New Highly Inert GC Columns for Challenging Environmental Semivolatiles Analysis


1/23/2013 10:31:23 AM

Torrance, CA (January 22, 2013) - Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces Zebron ZB-SemiVolatiles GC columns. Specially designed for the separation of semivolatile compounds, the new columns feature Phenomenex's proprietary Enviro-Inert technology, which improves column inertness for ultra-low-level detection without altering selectivity. Zebron ZB-SemiVolatiles GC columns separate 135 compounds in under 14 minutes, and exceed the demands of EPA 8270D suitability requirements. Available now in the U.S. and Canada, the new columns are ideal for semivolatile compound analysis in drinking water, wastewater and soil samples and other environmental applications.

Zebron ZB-SemiVolatiles GC columns deliver rugged performance in addition to improved peak shapes and response for acids, amines and PAHs, compared to other products on the market. The new offering provides the same elution order when switching from other five percent phenyl-arylene columns. Zebron columns hold calibration and are rugged enough to withstand multiple injections, for long life and reduced downtime.

Each ZB-SemiVolatiles GC column is individually QC-tested using two rigorous, specially designed mixes. The first is a traditional mix that tests for efficiency, selectivity, bleed and general activity. The second is the 8270D tune mix, which includes an MS tuning standard (DFTPP), the 8270D suitability compounds (Benzidine, Pentachlorophenol, and DDT) and an additional test probe (Pyridine, an active base). "No other manufacturer uses this second test mix, which is even more rigorous than what is required for EPA system suitability, and competing columns fail our QC tests," explains Kory Kelly, technical manager for GC and environmental products at Phenomenex. "This gives our customers confidence because the column has already passed the suitability requirements for this demanding method."

Ryan McKernan of TestAmerica, Inc. is an early user of the Zebron ZB-SemiVolatiles GC column. "I have found the Phenomenex ZB-SemiVolatiles columns to be superior in quality and durability to any other products we have used. The columns not only last longer, but the reproducibility is extraordinary," he said. "The column holds calibrations particularly well, even after multiple injections of samples with difficult matrices. All of this equates to less downtime and maintenance and more productivity for TestAmerica."

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, government, and academic laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.

For more information on Phenomenex, visit www.phenomenex.com or follow the company on Twitter @Phenomenex.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES